N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US 6,159,485 Surrendered on reissueSurrendered on reissue May 18, 2010 · From the USPTO record
20-year base term ended Jan 8, 2019
Surrendered on reissue May 18, 2010 · its term and maintenance fees continue in US RE41,339 and US RE42,902 and US RE44,017 and US RE44,302.
Jan 8, 1999
May 18, 2010
Dec 12, 2000
Jan 8, 2019
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 8, 1999, when this application, 09/227,213, was filed | Jan 8, 2019 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | None on file | no change | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds | no change | USPTO record |
| Reissue | US RE41,339 and US RE42,902 and US RE44,017 and US RE44,302 issued May 18, 2010, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered May 18, 2010 | USPTO record |
| Surrendered on reissue | The steps above, in order | May 18, 2010 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.